doi: 10.1016/S1474-4422(18)30403-4 8 Grabska-KobyeckaI.SzpakowskiP.KrlA.Ksiek-WiniarekD.KobyeckiA.GbiskiA.et al
The heritage and base might be insulin, but GLP-1 is the growth driver
Clinical Efficacy at Each Dose In the SUSTAIN program, semaglutide 1.0 mg reduced HbA1c by 1.5% to 1.8% across trials, with weight loss ranging from 4.5 kg to 6.5 kg at 30 to 56 weeks [3]
Indeed, GSH, Trx, Grx, Prx (together with the enzymes catalyzing their reduction), and the enzymatic antioxidant defense, as a whole, concur to modulate either ROS concentration, or the availability of cellular thiols, thus regulating the function of a large number of proteins implicated in the induction and/or execution of redox-sensitive pathways
[x] Shaefer CF Jr, Kushner P, Aguilar R